{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:00Z","timestamp":1786118820098,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/yct.0b013e3181571c0e","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T03:11:22Z","timestamp":1219979482000},"page":"236-238","source":"Crossref","is-referenced-by-count":9,"title":["The Safety of the Electroconvulsive Therapy-Aripiprazole Combination"],"prefix":"10.1097","volume":"24","author":[{"given":"Vasilios G.","family":"Masdrakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Oulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iannis M.","family":"Zervas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos A.","family":"Karakatsanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios V.","family":"Kouzoupis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Karapoulios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin R.","family":"Soldatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0327(00)00367-0","article-title":"Convulsive therapy: a review of the first 55 years.","volume":"63","author":"Fink","year":"2001","journal-title":"J Affect Disord"},{"key":"R2-12-20210126","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1520-6394(2000)12:3<130::AID-DA4>3.0.CO;2-C","article-title":"Side effects of electroconvulsive therapy.","volume":"12","author":"Datto","year":"2000","journal-title":"Depress Anxiety"},{"key":"R3-12-20210126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.yct.0000165500.60784.05","article-title":"The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia.","volume":"21","author":"Braga","year":"2005","journal-title":"J ECT"},{"key":"R4-12-20210126","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/15622970500395280","article-title":"The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.","volume":"7","author":"Nothdurfter","year":"2006","journal-title":"World J Biol Psychiatry"},{"key":"R5-12-20210126","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00124509-200603000-00013","article-title":"Combined use of electroconvulsive therapy and antipsychotics in schizophrenia: the Indian evidence. A review and a meta-analysis.","volume":"22","author":"Painuly","year":"2006","journal-title":"J ECT"},{"key":"R6-12-20210126","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00406-005-0587-5","article-title":"Antipsychotic and antidepressive effects of second generation antipsychotics. Two different pharmacological mechanisms?","volume":"255","author":"Moller","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R7-12-20210126","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.","volume":"302","author":"Burris","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R8-12-20210126","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.pnpbp.2004.06.020","article-title":"Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism.","volume":"28","author":"Naber","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R9-12-20210126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/IJAMH.2005.17.2.187","article-title":"Aripiprazole for agitation in a 13-year-old girl with neuroleptic malignant syndrome.","volume":"17","author":"Dew","year":"2005","journal-title":"Int J Adolesc Med Health"},{"key":"R11-12-20210126","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00124509-200309000-00004","article-title":"Thyrotropin-releasing hormone administration does not affect seizure threshold during electroconvulsive therapy.","volume":"19","author":"Zervas","year":"2003","journal-title":"J ECT"},{"key":"R12-12-20210126","first-page":"138","article-title":"The 'half-age' stimulation strategy for ECT dosing.","volume":"12","author":"Petrides","year":"1996","journal-title":"Convuls Ther"},{"key":"R14-12-20210126","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00124509-200206000-00005","article-title":"Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: a prospective, open trial.","volume":"18","author":"Tang","year":"2002","journal-title":"J ECT"},{"key":"R15-12-20210126","first-page":"385","article-title":"The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy.","volume":"57","author":"Gazdag","year":"2004","journal-title":"Ideggyogy Sz"},{"key":"R16-12-20210126","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/01.WNF.0000220816.86478.84","article-title":"Treatment of catatonic stupor with combination of modified electroconvulsive treatment and olanzapine: a case report.","volume":"29","author":"Tan","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"R17-12-20210126","first-page":"CD004578","article-title":"Aripiprazole for schizophrenia.","volume":"2","author":"El-Sayeh","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-12-20210126","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2165\/00003495-200464150-00010","article-title":"Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.","volume":"64","author":"Swainston Harrison","year":"2004","journal-title":"Drugs"},{"key":"R19-12-20210126","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.","volume":"20","author":"Sachs","year":"2006","journal-title":"J Psychopharmacol"},{"key":"R20-12-20210126","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.4088\/JCP.v66n1017","article-title":"Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment resistant major depressive disorder.","volume":"66","author":"Papakostas","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R21-12-20210126","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4088\/JCP.v66n1002","article-title":"Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.","volume":"66","author":"Simon","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R22-12-20210126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00124509-200003000-00005","article-title":"Seizure activity and safety in combined treatment with venlafaxine and ECT: a pilot study.","volume":"16","author":"Bernardo","year":"2000","journal-title":"J ECT"},{"key":"R23-12-20210126","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/15622970500213871","article-title":"The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.","volume":"7","author":"Baghai","year":"2006","journal-title":"World J Biol Psychiatry"}],"container-title":["The Journal of ECT"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00124509-200809000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:03:53Z","timestamp":1786035833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124509-200809000-00012"}},"subtitle":["Four Case Reports"],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/yct.0b013e3181571c0e","relation":{},"ISSN":["1095-0680"],"issn-type":[{"value":"1095-0680","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}